US 8273761
Tricyclic compound and medical use thereof
granted A61PA61P25/00A61P25/20
Quick answer
US patent 8273761 (Tricyclic compound and medical use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61P, A61P25/00, A61P25/20, A61P25/22, A61P25/24